Brian A. Van Tine, Ph.D. - Publications

2003 University of Alabama, Birmingham, Birmingham, AL, United States 

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ohman KA, Hashim YM, Vangveravong S, Nywening TM, Cullinan DR, Goedegebuure SP, Liu J, Van Tine BA, Tiriac H, Tuveson DA, DeNardo DG, Spitzer D, Mach RH, Hawkins WG. Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic. Oncotarget. PMID 27244881 DOI: 10.18632/Oncotarget.9551  0.8
2016 Lange SE, Zheleznyak A, Studer M, O'Shannessy DJ, Lapi SE, Van Tine BA. Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications. Oncotarget. PMID 26909615 DOI: 10.18632/Oncotarget.7552  0.8
2015 Lange SE, Liu J, Adkins DR, Powell MA, Van Tine BA, Mutch DG. Improved Clinical Trial Enrollments for Uterine Leiomyosarcoma Patients After Gynecologic Oncology Partnership with a Sarcoma Center. Gynecologic Oncology. PMID 26718726 DOI: 10.1016/j.ygyno.2015.12.016  0.8
2015 Demetri GD, von Mehren M, Jones RL, Hensley ML, Schuetze SM, Staddon A, Milhem M, Elias A, Ganjoo K, Tawbi H, Van Tine BA, Spira A, Dean A, Khokhar NZ, Park YC, et al. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26371143 DOI: 10.1200/JCO.2015.62.4734  0.8
2015 Movva S, Wen W, Chen W, Millis SZ, Gatalica Z, Reddy S, von Mehren M, Van Tine BA. Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets. Oncotarget. 6: 12234-47. PMID 25906748  0.8
2015 D' Angelo SP, Mahoney MR, Van Tine BA, Adkins DR, Perdekamp MT, Condy MM, Luke JJ, Hartley EW, Antonescu CR, Tap WD, Schwartz GK. Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma. Cancer Chemotherapy and Pharmacology. 75: 629-38. PMID 25672915 DOI: 10.1007/s00280-015-2689-8  0.8
2014 Dong Y, Van Tine BA, Oyama T, Wang PI, Cheng EH, Hsieh JJ. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis. Cell Research. 24: 1354-66. PMID 25267403 DOI: 10.1038/Cr.2014.129  0.8
2014 Van Tine BA. Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancer. Mlo: Medical Laboratory Observer. 46: 18, 20-1. PMID 25252395  0.8
2014 Zhang K, Jones L, Lim S, Maher CA, Adkins D, Lewis J, Kimple RJ, Fertig EJ, Chung CH, Van Tine BA, Ellis MJ, Herrlich A, Michel LS. Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC. Oncotarget. 5: 9281-94. PMID 25238142 DOI: 10.18632/Oncotarget.2423  0.8
2014 Chawla SP, Cranmer LD, Van Tine BA, Reed DR, Okuno SH, Butrynski JE, Adkins DR, Hendifar AE, Kroll S, Ganjoo KN. Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3299-306. PMID 25185097 DOI: 10.1200/JCO.2013.54.3660  0.8
2014 Adenis A, Blay JY, Bui-Nguyen B, Bouché O, Bertucci F, Isambert N, Bompas E, Chaigneau L, Domont J, Ray-Coquard I, Blésius A, Van Tine BA, Bulusu VR, Dubreuil P, Mansfield CD, et al. Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 1762-9. PMID 25122671 DOI: 10.1093/annonc/mdu237  0.8
2014 von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, ... ... Van Tine BA, et al. Gastrointestinal stromal tumors, version 2.2014. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 853-62. PMID 24925196  0.8
2014 Shoushtari AN, Van Tine BA, Schwartz GK. Novel treatment targets in sarcoma: more than just the GIST. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. e488-95. PMID 24857144 DOI: 10.14694/EdBook_AM.2014.34.e488  0.8
2014 von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, Delaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, ... ... Van Tine BA, et al. Soft tissue sarcoma, version 2.2014. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 473-83. PMID 24717567  0.8
2014 Schenone AD, Luo J, Montgomery L, Morgensztern D, Adkins DR, Van Tine BA. Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy. Cancer Medicine. 3: 603-12. PMID 24574357 DOI: 10.1002/cam4.209  0.8
2014 Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, Gutmann DH. BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Neuro-Oncology. 16: 466-7. PMID 24366910 DOI: 10.1093/Neuonc/Not248  0.8
2013 Frith AE, Hirbe AC, Van Tine BA. Novel pathways and molecular targets for the treatment of sarcoma. Current Oncology Reports. 15: 378-85. PMID 23661264 DOI: 10.1007/S11912-013-0319-3  0.8
2013 Schwartz GK, Tap WD, Qin LX, Livingston MB, Undevia SD, Chmielowski B, Agulnik M, Schuetze SM, Reed DR, Okuno SH, Ludwig JA, Keedy V, Rietschel P, Kraft AS, Adkins D, ... Van Tine BA, et al. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. The Lancet. Oncology. 14: 371-82. PMID 23477833 DOI: 10.1016/S1470-2045(13)70049-4  0.8
2012 von Mehren M, Benjamin RS, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S, Gonzalez R, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, ... ... Van Tine BA, et al. Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 951-60. PMID 22878820  0.8
2012 Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 486: 353-60. PMID 22722193 DOI: 10.1038/Nature11143  0.8
2012 Chen DY, Lee Y, Van Tine BA, Searleman AC, Westergard TD, Liu H, Tu HC, Takeda S, Dong Y, Piwnica-Worms DR, Oh KJ, Korsmeyer SJ, Hermone A, Gussio R, Shoemaker RH, et al. A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth. Cancer Research. 72: 736-46. PMID 22166309 DOI: 10.1158/0008-5472.Can-11-2584  0.8
2011 Van Tine BA, Crowder RJ, Ellis MJ. ER and PI3K independently modulate endocrine resistance in ER-positive breast cancer. Cancer Discovery. 1: 287-8. PMID 22096658 DOI: 10.1158/2159-8290.CD-11-0192  0.8
2011 Van Tine BA, Ellis MJ. Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginning. Journal of the National Cancer Institute. 103: 526-7. PMID 21447809 DOI: 10.1093/jnci/djr072  0.8
2010 Chen DY, Liu H, Takeda S, Tu HC, Sasagawa S, Van Tine BA, Lu D, Cheng EH, Hsieh JJ. Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis. Cancer Research. 70: 5358-67. PMID 20516119 DOI: 10.1158/0008-5472.Can-10-0027  0.8
2007 Sadlonova A, Mukherjee S, Bowe DB, Gault SR, Dumas NA, Van Tine BA, Frolova N, Page GP, Welch DR, Novak L, Frost AR. Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease. The American Journal of Pathology. 170: 1064-76. PMID 17322389 DOI: 10.2353/Ajpath.2007.060031  0.8
2006 Dao LD, Dufly A, Van Tine BA, Wu SY, Chiang CM, Broker TR, Chow LT. Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus Journal of Virology. 80: 4792-4800. PMID 16641272 DOI: 10.1128/Jvi.80.10.4792-4800.2006  0.8
2006 Whisenhunt TR, Yang X, Bowe DB, Paterson AJ, Van Tine BA, Kudlow JE. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology. 16: 551-63. PMID 16505006 DOI: 10.1093/Glycob/Cwj096  0.8
2005 Van Tine BA, Broker TR, Chow LT. Simultaneous in situ detection of RNA, DNA, and protein using tyramide-coupled immunofluorescence. Methods in Molecular Biology (Clifton, N.J.). 292: 215-230. PMID 15507711 DOI: 10.1385/1-59259-848-X:215  0.8
2004 Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RDM, Meijer CLJM, Snijders PJF, Chatis P, Broker TR, Moen PT, Chow LT. Clonal selection for transcriptionally active viral oncogenes during progression to cancer Journal of Virology. 78: 11172-11186. PMID 15452237 DOI: 10.1128/Jvi.78.20.11172-11186.2004  0.8
2004 Van Tine BA, Dao LD, Wu SY, Sonbuchner TM, Lin BY, Zou N, Chiang CM, Broker TR, Chow LT. Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning Proceedings of the National Academy of Sciences of the United States of America. 101: 4030-4035. PMID 15020762 DOI: 10.1073/Pnas.0306848101  0.8
2004 Wood JC, Quinn G, Suling KM, Oldmixon BA, Van Tine BA, Cina R, Arn S, Huang CA, Scobie L, Onions DE, Sachs DH, Schuurman HJ, Fishman JA, Patience C. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine. Journal of Virology. 78: 2494-501. PMID 14963150 DOI: 10.1128/JVI.78.5.2494-2501.2004  0.8
2003 Van Tine BA, Patterson A, Kudlow JE. Assignment of N-acetyl-D-glucosaminidase (Mgea5) to rat chromosome 1q5 by tyramide fluorescence in situ hybridization (T-FISH): synteny between rat, mouse and human with Insulin Degradation Enzyme (IDE). Cytogenetic and Genome Research. 103: 202B. PMID 15008141 DOI: 10.1159/000076313  0.8
2003 Deng W, Jin G, Lin BY, Van Tine BA, Broker TR, Chow LT. mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. Journal of Virology. 77: 10213-26. PMID 12970406 DOI: 10.1128/Jvi.77.19.10213-10226.2003  0.8
2002 Young GD, Winokur TS, Cerfolio RJ, Van Tine BA, Chow LT, Okoh V, Garver RI. Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes. Lung Cancer (Amsterdam, Netherlands). 36: 133-41. PMID 11955647 DOI: 10.1016/S0169-5002(01)00486-X  0.8
2001 Van Tine BA, Knops J, Broker TR, Chow LT, Moen PT. In situ analysis of the transcriptional activity of integrated viral DNA using tyramide-FISH. Developments in Biologicals. 106: 381-5. PMID 11761253  0.8
2001 Mahalingam S, Van Tine B, Santiago ML, Gao F, Shaw GM, Hahn BH. Functional analysis of the simian immunodeficiency virus Vpx protein: Identification of packaging determinants and a novel nuclear targeting domain Journal of Virology. 75: 362-374. PMID 11119605 DOI: 10.1128/Jvi.75.1.362-374.2001  0.8
2000 Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, Wang J, Qin J, Chow LT, Harper JW. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes & Development. 14: 2298-313. PMID 10995387 DOI: 10.1101/Gad.829500  0.8
1999 Van Tine BA, Knops J, Shaw GM, May WA. Assignment of human MFNG, manic fringe Drosophila homolog, to 22q13.1 using tyramide fluorescence in situ hybridization (T-FISH). Cytogenetics and Cell Genetics. 87: 132-3. PMID 10640833  0.8
1999 Van Tine BA, Shaw GM, Aldrovandi G. Mother-to-infant transmission of the human immunodeficiency virus during primary infection. The New England Journal of Medicine. 341: 1548. PMID 10577111 DOI: 10.1056/NEJM199911113412014  0.36
1999 Jian Y, Van Tine BA, Chien WM, Shaw GM, Broker TR, Chow LT. Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 10: 101-11. PMID 10074904  0.8
1999 Swindle CS, Zou N, Van Tine BA, Shaw GM, Engler JA, Chow LT. Human papillomavirus DNA replication compartments in a transient DNA replication system. Journal of Virology. 73: 1001-9. PMID 9882301 DOI: 10.1128/Jvi.73.2.1001-1009.1999  0.8
1998 Tousson A, Van Tine BA, Naren AP, Shaw GM, Schwiebert LM. Characterization of CFTR expression and chloride channel activity in human endothelia. The American Journal of Physiology. 275: C1555-64. PMID 9843717 DOI: 10.1152/Ajpcell.1998.275.6.C1555  0.8
1998 Van Tine BA, Knops JF, Butler A, Deloukas P, Shaw GM, King PH. Localization of HuC (ELAVL3) to chromosome 19p13.2 by fluorescence in situ hybridization utilizing a novel tyramide labeling technique. Genomics. 53: 296-9. PMID 9799595 DOI: 10.1006/geno.1998.5468  0.8
Show low-probability matches.